Results 31 to 40 of about 5,335 (235)
Plaque-adaptive flexible film dosimetry system for Ru-106 plaque brachytherapy commissioning and quality assurance. [PDF]
Med PhysAbstract Background Ruthenium‐106 (Ru‐106) plaque brachytherapy is an established treatment modality for choroidal melanoma that delivers localized beta radiation while sparing surrounding ocular structures. It is widely used in Europe and parts of Asia, whereas COMS Iodine‐125 and Palladium‐103 plaques remain the standard in the United States. However,
Cho JD +5 more
europepmc +2 more sources
Plaque brachytherapy in iris and iridociliary melanoma: a systematic review of efficacy and complications. [PDF]
J Contemp Brachytherapy, 2021 Karimi S, Arabi A, Shahraki T.
europepmc +3 more sources
Retina dose as a predictor for visual acuity loss in 106 Ru eye plaque brachytherapy of uveal melanomas [PDF]
Radiotherapy and Oncology, 2018 Gerd Heilemann +2 more
exaly +2 more sources
Outpatient ocular brachytherapy: The USC Experience
Advances in Radiation Oncology, 2021 Purpose: Ocular brachytherapy is a standard-of-care surgical procedure for globe salvage in the treatment of uveal melanoma. The procedure involves the placement and subsequent removal of a radioactive plaque several days later.
Sarah Joh, BS +6 more
doaj +1 more source
Medical Physics, Volume 53, Issue 5, May 2026.Abstract Purpose To develop and benchmark eye plaque models for Monte Carlo (MC) simulation of iris melanoma brachytherapy and to develop a database of 3D dose distributions for the iris plaques containing 103Pd${}^{103}{\rm Pd}$, 125I${}^{125}{\rm I}$, and 131Cs${}^{131}{\rm Cs}$ seeds.
Marwa Djedouani +3 more
openalex +2 more sources
Ruthenium-106 plaque brachytherapy for the treatment of diffuse choroidal hemangioma in Sturge-Weber syndrome [PDF]
International Journal of Ophthalmology, 2020 "AIM: To evaluate the efficacy of ruthenium-106 plaque brachytherapy for the treatment of diffuse choroidal hemangioma (DCH) in Sturge-Weber syndrome (SWS).
Ying-Ying Yu +2 more
doaj +1 more source
Journal of Contemporary Brachytherapy, 2022 Medulloepithelioma is the second most common type of pediatric intra-ocular tumors. It commonly arises from ciliary body, and it is generally diagnosed in the first decade of life. Management options for medulloepithelioma include enucleation, resection,
Amparo Ortiz-Seller +5 more
doaj +1 more source
Local treatment failure after globe-conserving therapy for choroidal melanoma. [PDF]
, 2013 Local treatment failure after globe-conserving therapy for choroidal melanoma is a surgical complication with significant morbidity to the vision and eye. Few reports in the literature have addressed this complication exclusively.
Chang, Melinda Y, McCannel, Tara A
core +1 more source
125I plaque brachytherapy for anterior uveal melanomas [PDF]
Eye, 2004 To describe the results of 125I plaque brachytherapy of uveal melanomas anterior to the equator in terms of local control and the associated complications while trying to identify their risk factors (patients' demographic data, ocular, and tumour characteristics).Retrospective analysis of a series of patients treated by 125I between 1990 and 2000 in a ...
L, Lumbroso-Le Rouic +8 more
openaire +2 more sources
Cost-effectiveness of proton beam therapy for intraocular melanoma. [PDF]
PLoS ONE, 2015 Proton beam therapy is a commonly accepted treatment for intraocular melanomas, but the literature is lacking in descriptions of patient preferences of clinical outcomes and economic impact.
James P Moriarty +4 more
doaj +1 more source